论文部分内容阅读
浙江杭州鑫富药业股份有限公司,从一家默默无闻的小厂,成长为全球泛酸行业的领跑者和首批中小企业上市公司。2007年,公司实现销售总收入7.6亿元,利税4亿元。科技创新是企业的推进器,公司拥有多项自主知识产权。其中泛酸领域最尖端的生物酶拆分技术,2003年获得了国家技术发明二等奖(一等奖缺)及省、市多项大奖。为公司奠定了D-泛酸钙质量、产量世界第一的坚实基础。鑫富药业的前身是临安申光电缆厂。1994年,企业创始人过鑫富敏锐地觉察到了维生素B(5即D-泛酸钙)的商机,
Zhejiang Hangzhou Xin Fu Pharmaceutical Co., Ltd., from a small factory unknown, the world’s pantothenic acid industry leader and the first batch of listed SMEs. In 2007, the company achieved a total sales revenue of 760 million yuan, profits and taxes 400 million yuan. Scientific and technological innovation is the propeller of the company, the company has a number of independent intellectual property rights. One of the most sophisticated pantothenic acid in the field of enzyme separation technology, in 2003 won the second prize of national technology invention (lack of first prize) and provincial and municipal awards. For the company laid D-calcium pantothenate, the output of a solid foundation for the world. Xin Fu Pharmaceutical predecessor is Lin’an Shen light cable plant. In 1994, the founder of the company Xinfu keenly aware of the vitamin B (5 D-calcium pantothenate) business opportunities,